MedPath

Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia

Not Applicable
Not yet recruiting
Conditions
GDM
Registration Number
NCT07141173
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Brief Summary

This study aims to explore whether early intervention for high-risk groups of gestational hyperglycemia can improve insulin resistance and effectively prevent the occurrence of GDM, and evaluate which pathophysiological subtypes of GDM have the best effect on improving maternal and fetal adverse prognosis, so as to provide evidence for stratified management and individualized clinical intervention of high glucose groups in pregnancy

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
604
Inclusion Criteria
  • 18-55 years old
  • 6-14 weeks of pregnancy
  • at least one risk factor for GDM
  • signed a written informed consent
Exclusion Criteria
  • Individuals diagnosed with diabetes or prediabetes prior to pregnancy
  • currently taking medications affecting blood glucose levels such as metformin
  • women at risk of miscarriage
  • individuals with chronic conditions (such as uncontrolled hypertension, severe heart disease)
  • those with movement disorders or contraindicated conditions for physical activity
  • patients undergoing gastrointestinal surgeries that alter glucose absorption
  • those unable to maintain regular prenatal care (such as non-compliance with medical instructions or mental health issues).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The incidence of gestational diabetes(GDM)24-28 weeks pregnant

The 75g 2h oral glucose tolerance test is performed at 24-28 weeks of gestation, and the cut-off points of venous blood glucose values are 5.1mmol/L (fasting), 10.0mmol/L (1h after glucose load), 8.5mmol/L (2h after glucose load). If any one of the three blood glucose measures is above the cut-off points, then GDM is diagnosed..

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tianjin Central Hospital of Gynecology Obstetrics

🇨🇳

Tianjin, China

Tianjin Central Hospital of Gynecology Obstetrics
🇨🇳Tianjin, China
Yifan Fan
Contact
+86 58287942
592773020@qq.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.